Saved in:
Bibliographic Details
Main Authors: Alfred Honoré, Karsten Gravdal, Patrick Juliebø‐Jones, Lars Anders Rokne Reisæter, Christian Beisland, Christian Arvei Moen
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.486
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867021622246899713
author Alfred Honoré
Karsten Gravdal
Patrick Juliebø‐Jones
Lars Anders Rokne Reisæter
Christian Beisland
Christian Arvei Moen
author_facet Alfred Honoré
Karsten Gravdal
Patrick Juliebø‐Jones
Lars Anders Rokne Reisæter
Christian Beisland
Christian Arvei Moen
Alfred Honoré
Karsten Gravdal
Patrick Juliebø‐Jones
Lars Anders Rokne Reisæter
Christian Beisland
Christian Arvei Moen
collection Wiley Open Access
contents Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy Alfred Honoré Karsten Gravdal Patrick Juliebø‐Jones Lars Anders Rokne Reisæter Christian Beisland Christian Arvei Moen BJUI Compass AbstractObjectiveTransrectal (TR) prostate biopsy is being increasingly abandoned in favour of a transperineal (TP) approach as well as a targeted biopsy only of the index lesion(s). It remains underreported how these changes could impact concordance at final pathology. We aimed to evaluate the impact of transitioning from standard transrectal (sTR) to cognitive targeted transperineal (cog‐tTP) biopsy on final pathology including concordance and upgrading.Material and methodsAnalysis of consecutive patients undergoing prostate biopsy and prostatectomy (RP) between January 2018 and May 2022 at a tertiary centre in Western Norway.ResultsThere were 210 and 239 patients in the sTR and cog‐tTP groups, respectively. The mean [IQR] number of biopsies decreased from 12 [4–12] to 3 [3–4] (p < 0.001). The overall rate of concordance between biopsy and final pathology was 64% in both groups (Table 3, Figure 1). 24% Twenty‐four per cent (cog‐tTP) versus 19% (sTR) had grade group (GG) upgrading, while 12% versus 17% were downgraded (p = 0.2). Regarding positive surgical margins (PSMs) that were >3 mm in extension, there were only 3.3% and 2.1% in the sTR and cog‐tTP groups, respectively (p = 0.4). For surgical outcomes associated with RP, no differences in terms of postoperative complications between the groups were found (cog‐tTP:10% vs. sTR:6%, p = 0.10).ConclusionTransitioning from sTR biopsy to targeted cog‐tTP biopsy does not compromise concordance at final pathology nor does it increase the risk of tumour upgrading. 10.1002/bco2.486 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/bco2.486
format Artículo Open Access
id wiley_oa_10_1002_bco2_486
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy
Alfred Honoré
Karsten Gravdal
Patrick Juliebø‐Jones
Lars Anders Rokne Reisæter
Christian Beisland
Christian Arvei Moen
BJUI Compass
Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy Alfred Honoré Karsten Gravdal Patrick Juliebø‐Jones Lars Anders Rokne Reisæter Christian Beisland Christian Arvei Moen BJUI Compass AbstractObjectiveTransrectal (TR) prostate biopsy is being increasingly abandoned in favour of a transperineal (TP) approach as well as a targeted biopsy only of the index lesion(s). It remains underreported how these changes could impact concordance at final pathology. We aimed to evaluate the impact of transitioning from standard transrectal (sTR) to cognitive targeted transperineal (cog‐tTP) biopsy on final pathology including concordance and upgrading.Material and methodsAnalysis of consecutive patients undergoing prostate biopsy and prostatectomy (RP) between January 2018 and May 2022 at a tertiary centre in Western Norway.ResultsThere were 210 and 239 patients in the sTR and cog‐tTP groups, respectively. The mean [IQR] number of biopsies decreased from 12 [4–12] to 3 [3–4] (p < 0.001). The overall rate of concordance between biopsy and final pathology was 64% in both groups (Table 3, Figure 1). 24% Twenty‐four per cent (cog‐tTP) versus 19% (sTR) had grade group (GG) upgrading, while 12% versus 17% were downgraded (p = 0.2). Regarding positive surgical margins (PSMs) that were >3 mm in extension, there were only 3.3% and 2.1% in the sTR and cog‐tTP groups, respectively (p = 0.4). For surgical outcomes associated with RP, no differences in terms of postoperative complications between the groups were found (cog‐tTP:10% vs. sTR:6%, p = 0.10).ConclusionTransitioning from sTR biopsy to targeted cog‐tTP biopsy does not compromise concordance at final pathology nor does it increase the risk of tumour upgrading. 10.1002/bco2.486 http://creativecommons.org/licenses/by/4.0/
title Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy
topic BJUI Compass
url https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.486